Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: A population-based cohort study using the Shizuoka Kokuho database

Nanako Ubukata; Hideo Hashizume; Eiji Nakatani; Hatoko Sasaki; Yoshiki Miyachi

doi:10.1016/j.jaad.2024.05.053

Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: A population-based cohort study using the Shizuoka Kokuho database

J Am Acad Dermatol. 2024 Sep;91(3):573-575. doi: 10.1016/j.jaad.2024.05.053. Epub 2024 May 23.

Authors

Nanako Ubukata¹, Hideo Hashizume², Eiji Nakatani³, Hatoko Sasaki¹, Yoshiki Miyachi¹

Affiliations

¹ Shizuoka Graduate University of Public Health, Shizuoka, Japan.
² Shizuoka Graduate University of Public Health, Shizuoka, Japan; Department of Dermatology, Iwata City Hospital, lwata, Shizuoka, Japan.
³ Shizuoka Graduate University of Public Health, Shizuoka, Japan. Electronic address: nakatani.eiji.int@gmail.com.

PMID: 38796078
DOI: 10.1016/j.jaad.2024.05.053

No abstract available

Keywords: cohort study; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome (DIHS); epidemiology (DRESS); insurance claim; risk factor; severe cutaneous adverse reaction.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Cohort Studies
Databases, Factual*
Drug Hypersensitivity Syndrome* / diagnosis
Drug Hypersensitivity Syndrome* / epidemiology
Drug Hypersensitivity Syndrome* / etiology
Female
Humans
Japan / epidemiology
Male
Middle Aged
Retrospective Studies
Risk Factors
Young Adult